NEW YORK (360Dx) – Theranos is laying off 155 employees, or 41 percent of its workforce, in order to focus on commercializing its miniLab testing technology, the firm said on Friday.

After the layoffs, Theranos will have 220 employees tasked with product development and regulatory and commercial efforts. In a statement the firm said the decision to trim its operations was difficult. "[H]owever this move allows Theranos to marshal its resources most efficiently and effectively."

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.